Litfulo

Active Ingredient(s): Ritlecitinib
FDA Approved: * June 23, 2023
Pharm Company: * PFIZER INC
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Litfulo 50 mg Oral Capsule
NDC: 0069-0334
Labeler:
Pfizer Laboratories Div Pfizer Inc
Litfulo 50 mg Oral Capsule
NDC: 63539-334
Labeler:
U.S. Pharmaceuticals